Penn Center for Innovation Files 5,000 Patents in 14 Years at $30,000 Each

The University of Pennsylvania has filed nearly 5,000 patent applications since September 2012. The majority of these applications relate to medical discoveries. The Penn Center for Innovation, established in 2014, manages this pipeline and determines which inventions warrant the financial investment.

Benjamin Dibling, the managing director of the center, stated that the goal is to maximize the impact of Penn's research output. He described commercialization as a path parallel to traditional academic publication. Dibling noted that the center files patents for technologies that are in early stages. The primary incentive is securing an exclusive market position for a fixed period. This prevents unrelated companies from releasing identical competing products.

The process begins when researchers submit an invention disclosure. This is mandatory for any patentable discovery funded by federal or sponsored research. Dibling explained that the center then evaluates whether the technology can become a new product, service, or business.

The legal timeline is lengthy. A typical utility patent application spends about two years pending at the United States Patent and Trademark Office. The USPTO often rejects initial applications in an Official Action letter. This starts a back-and-forth negotiation with patent attorneys that can last several years. Dibling observed that the patent office prefers narrow patents, while Penn often seeks broader protections.

The university relies on outside patent counsel for this work. The Office of General Counsel signs off on these collaborations but rarely intervenes directly. Dibling said the Office of General Counsel usually steps in only during patent infringement lawsuits.

The financial cost of the process is substantial. The total expense from filing to issuance ranges from $15,000 to $30,000 per application. The Penn Center for Innovation covers all of these costs. According to the university's Patent Policy, Penn owns inventions created by its personnel, including faculty, postdocs, and graduate students on research grants. The center actively manages licensing rights and patent maintenance.

Penn has been able to file patents on behalf of its researchers since the Leahy-Smith America Invents Act took effect in 2012. USPTO data indicates that filings have risen steadily since then. Since 2021, the university has maintained a filing rate of more than 400 applications per year.

Most granted patents fall under Cooperative Patent Classification sections A and C. These categories cover human necessities, such as medicinal preparations, and chemistry, including biochemical compounds. Three specific subsections dominate the portfolio: antineoplastic agents, T-cells, and viral vectors. The viral vector category alone contains 413 patents.

A spokesperson for the center wrote that securing a patent does not limit the academic freedom of researchers. They can continue to use patented inventions for academic purposes. Dibling acknowledged that the patent budget has limits. He stated that some faculty members do not realize the high cost of filing. He also noted that not every valuable technology requires patent protection to retain its worth.